Invesco Biotechnology & Genome ETF
PBE
NYSE Arca
| Weiss Ratings | PBE - NYSE Arca | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Fair | |||
| Reward Grade | C- | |||
| Risk Index | Weak | |||
| Risk Grade | D+ | |||
| Valuation | PBE - NYSE Arca | Click to Compare |
Click to Compare |
Click to Compare |
| Price | $99.20 | |||
| Company Info | PBE - NYSE Arca | Click to Compare |
Click to Compare |
Click to Compare |
| Provider | Invesco | |||
| Manager/Tenure (Years) | Peter Hubbard (19), Michael Jeanette (18), Pratik Doshi (6) | |||
| Website | http://www.invesco.com/us | |||
| Phone Number | 800-659-1005 | |||
| Fund Information | PBE - NYSE Arca | Click to Compare |
Click to Compare |
Click to Compare |
| Fund Name | Invesco Biotechnology & Genome ETF | |||
| Category | Health | |||
| Sub-Category | Healthcare Sector Equity | |||
| Prospectus Objective | Specialty - Health | |||
| Inception Date | Jun 23, 2005 | |||
| Open/Closed To New Investors | Open | |||
| Minimum Initial Investment | -- | |||
| Minimum Subsequent Investment | -- | |||
| Front End Fee | -- | |||
| Back End Fee | -- | |||
| Dividends and Shares | PBE - NYSE Arca | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Yield | 1.30% | |||
| Dividend | PBE - NYSE Arca | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Yield (Forward) | 0.43% | |||
| Asset Allocation | PBE - NYSE Arca | Click to Compare |
Click to Compare |
Click to Compare |
| Cash | 0.04% | |||
| Stock | 99.96% | |||
| U.S. Stock | 99.96% | |||
| Non-U.S. Stock | 0.00% | |||
| Bond | 0.00% | |||
| U.S. Bond | 0.00% | |||
| Non-U.S. Bond | 0.00% | |||
| Preferred | 0.00% | |||
| Convertible | 0.00% | |||
| Other Net | 0.00% | |||
| Price History | PBE - NYSE Arca | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -1.49% | |||
| 30-Day Total Return | 4.31% | |||
| 60-Day Total Return | 1.64% | |||
| 90-Day Total Return | 8.31% | |||
| Year to Date Total Return | 22.17% | |||
| 1-Year Total Return | 36.71% | |||
| 2-Year Total Return | 47.58% | |||
| 3-Year Total Return | 80.55% | |||
| 5-Year Total Return | 33.05% | |||
| Price | PBE - NYSE Arca | Click to Compare |
Click to Compare |
Click to Compare |
| Closing Price | $102.34 | |||
| 1-Month Low Price | $94.25 | |||
| 1-Month High Price | $103.46 | |||
| 52-Week Low Price | $73.76 | |||
| 52-Week Low Price (Date) | Nov 04, 2025 | |||
| 52-Week High Price | $103.46 | |||
| 52-Week High Price (Date) | Oct 29, 2026 | |||
| NAV | PBE - NYSE Arca | Click to Compare |
Click to Compare |
Click to Compare |
| 1-Month Low NAV | $94.23 | |||
| 1-Month High NAV | $103.39 | |||
| 52-Week Low NAV | $73.74 | |||
| 52-Week Low NAV (Date) | Nov 04, 2025 | |||
| 52-Week High NAV | $103.39 | |||
| 52-Week High Price (Date) | Oct 29, 2026 | |||
| Beta / Standard Deviation | PBE - NYSE Arca | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 0.62 | |||
| Standard Deviation | 16.29 | |||
| Balance Sheet | PBE - NYSE Arca | Click to Compare |
Click to Compare |
Click to Compare |
| Total Assets | 441.78M | |||
| Operating Ratios | PBE - NYSE Arca | Click to Compare |
Click to Compare |
Click to Compare |
| Expense Ratio | 0.59% | |||
| Turnover Ratio | 103.00% | |||
| Performance | PBE - NYSE Arca | Click to Compare |
Click to Compare |
Click to Compare |
| Last Bull Market Total Return | 32.96% | |||
| Last Bear Market Total Return | -6.74% | |||